Amphastar Pharmaceuticals, Inc. Logo

Amphastar Pharmaceuticals, Inc.

Develops and manufactures complex injectable, intranasal, and inhalation pharmaceutical products.

AMPH | US

Overview

Corporate Details

ISIN(s):
US03209R1032 (+3 more)
LEI:
54930055TH0ZLSAQMJ38
Country:
United States of America
Address:
11570 SIXTH STREET, 91730 RANCHO CUCAMONGA
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Amphastar Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development, manufacturing, and marketing of complex and technically challenging pharmaceutical products. The company's portfolio primarily consists of generic and proprietary injectable, intranasal, and inhalation drugs. It specializes in complex medications, including biologics, interchangeable biosimilars, and proteins, and also manufactures its own active pharmaceutical ingredients (APIs) such as insulin. Amphastar leverages its state-of-the-art, cGMP-compliant facilities to create innovative drug delivery systems and proprietary technological platforms, targeting difficult-to-produce medications.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-06 00:00
Investor Presentation
Q3 2025 Earnings Presentation
English 3.4 MB
2025-09-03 00:00
Investor Presentation
Wells Fargo Healthcare Presentation
English 3.0 MB

Automate Your Workflow. Get a real-time feed of all Amphastar Pharmaceuticals, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Amphastar Pharmaceuticals, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Amphastar Pharmaceuticals, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Anbio Biotechnology Logo
Develops and supplies in vitro diagnostic solutions for human and veterinary markets.
United States of America
NNNN
Anebulo Pharmaceuticals, Inc. Logo
Clinical-stage biotech developing an antidote for acute cannabinoid intoxication in ER patients.
United States of America
ANEB
AnGes, Inc. Logo
Develops gene-based medicines like HGF gene therapy, DNA vaccines, and NF-kB decoys.
Japan
4563
ANIMALCARE GROUP PLC Logo
Develops & sells veterinary prescription & OTC medicines for professionals worldwide.
United Kingdom
ANCR
ANI PHARMACEUTICALS INC Logo
Develops, manufactures, and markets branded/generic drugs and OTCs for niche therapeutic areas.
United States of America
ANIP
Annexin Pharmaceuticals AB Logo
Developing Annexin A5 protein to treat vascular, inflammatory, and cancerous diseases.
Sweden
ANNX
Annexon, Inc. Logo
Developing C1q inhibitors for autoimmune, neurodegenerative, and ophthalmic diseases.
United States of America
ANNX
ANTEROGEN CO., LTD. Logo
Develops and commercializes adult stem cell therapies and orphan drugs for medical conditions.
South Korea
065660
Antibiotice S.A. Logo
Develops and manufactures generic medicines and APIs, specializing in anti-infectives.
Romania
ATB
Apellis Pharmaceuticals, Inc. Logo
Developing novel C3 therapies for diseases in ophthalmology, nephrology, and hematology.
United States of America
APLS

Talk to a Data Expert

Have a question? We'll get back to you promptly.